Adare BIOME: DSM: 'Postbiotics deal will make us frontrunner in microbiome management'
DSM is in exclusive negotiations with Adare Pharma Solutions in order to acquire Adare Biome, a pioneer in the development and manufacturing of postbiotics, for â275m.
Read full article »
Adare Biome is a France-based CDMO that develops and produces postbiotic products for the pharmaceutical industry.
Read more